A plasma-based analysis and genomic landscape of patients with high tumor mutational burden (TMB-H), microsatellite stable (MSS) colorectal cancer (CRC). This is an ASCO Meeting Abstract from the 2023 ...
Comprehensive genomic and transcriptomic profiling (CGTP) to predict pembrolizumab (P) benefit in patients (pts) with advanced solid tumors (STs). This is an ASCO Meeting Abstract from the 2021 ASCO ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果